Serum M2BPGi level is a novel predictive biomarker for the responses to pegylated interferon-α treatment in HBeAg-positive chronic hepatitis B patients.
Zhu MY, Chen PZ, Li J, Yu DM, Huang D, Zhu XJ, Han Y, Chen J, Huang W, Chen YY, Gong QM, Jiang JH, Zhang DH, Zhang Y, Zhang JM, Zhang XX.
Zhu MY, et al. Among authors: zhang dh, zhang jm, zhang xx, zhang y.
J Med Virol. 2018 Apr;90(4):721-729. doi: 10.1002/jmv.25010. Epub 2018 Jan 12.
J Med Virol. 2018.
PMID: 29247529
Free PMC article.